Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar cbbutton (< 20) Submitted: 7/19/2010 6:09:22 PM : Outperform Start Price: $42.24 SLXP Score: -4.34

strong pipline withhuge potential

Featured Broker Partners


Advertisement